Company
Product List
Offer to buy
Offer to sell
登入
加入會員
求助
Languages
English
繁體中文
簡體中文
Changchun Changsheng Life Sciences Ltd.
回首頁
公司簡介
產品櫥窗
影音視聽
寄出詢問函
聯絡我們
Recommended Results
Clinical hepatitis A vaccine
產品分類 :
化學->化學用品->aspalthic products
View Larger Picture
View Larger Picture
View Larger Picture
產品規格
Model No:
1.0ml/Vial
Country
CN
Minimum Order
5000
Payment Term
L/C,T/T
產品描述
<p class="MsoNormal">
<br />
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Hepatitis A susceptible individuals above the age of 18 months.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Function and use<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
The product can induce immunity against hepatitis A virus in recipients following immunization. It is used to prevent hepatitis A.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Description<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
The freeze-dried hepatitis A vaccine is a preparation made from the live attenuated strain of hepatitis A virus (HAV) grown in human diploid cell cultures. After cultivation, harvest and extraction of the virus, the virus suspension is lyophilized after adding an appropriate stabilizer to make the vaccine. It looks like a milky-white crisp cake and it turns into a clear liquid after reconstitution.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Active constituent: live attenuated Hepatitis A virus.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Subsidiary materials: All the components of subsidiary materials approved shall be listed.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Diluent: sterile water for injection.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Specifications<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
1.0 ml of reconstituted vaccine per container. 1.0 ml per single human dose containing not less than 6.50lg CCID50 of live hepatitis A virus.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Feature<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Advantages: 1.Accordance with the trend of biomedicine.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
2. Convenient for storage and transportation.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
3. The improvement of the stability of the vaccine,30-months of self life.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
4. The extension of the validation.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
5. More stable immune results
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
Results from the study group of National 95 Key Task Project:
</p>
<p class="MsoNormal" style="margin-left:21.0000pt;text-indent:-21.0000pt;text-align:justify;" align="justify">
100% safety for injection of live hepatitis A vaccine,freeze-dried
</p>
<p class="MsoNormal" style="margin-left:21.0000pt;text-indent:-21.0000pt;text-align:justify;" align="justify">
100% seroconversion rate after 2 dose injection
</p>
<p class="MsoNormal" style="margin-left:21.0000pt;text-indent:-21.0000pt;text-align:justify;" align="justify">
100% epidemiologic protective efficacy
</p>
<p class="MsoNormal" style="margin-left:21.0000pt;text-indent:-21.0000pt;text-align:justify;" align="justify">
lAll of the products passed the national quality control
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
1.HAV
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
2.freeze-dried vaccine
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
3.prevent hepatitis A
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
4.live attenuated strain
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<img src="http://i.bosscdn.com/product/8d/b4/e7/421c6c85283b4b96942a09f355.png@watermark=2&color=I0ZGRkZGRg%3D%3D&type=ZHJvaWRzYW5zZmFsbGJhY2s%3D&size=22&p=9&t=80&text=Y3MtdmFjY2luZS5ib3NzZ29vLmNvbQ%3D%3D" title="HAV" alt="HAV" />
</p>
<p>
<br />
</p>
<p>
<br />
</p>
<p class="MsoNormal">
<br />
</p>ccls-vaccine.com
其他類似產品
Lyophilized Meningococcal Polysaccharide Vaccine
Lyophilized Varicella Immunization Vaccine
Group A and C Meningococcal Polysaccharide Vaccine
Inactivated Flu Vaccine for human
[ Back Products Catalog ]
Commerce 會員:
請登入您的 帳號 跟 密碼, 系統將自動為您填入您的相關基本資料!
帳號:
密碼:
記住我的帳號
填寫下列表格並寄送詢問函.所有的詢問信函將會自動寄發給你想聯絡的公司
主旨
內容
﹙ 請勿輸入公司名稱、Email、電話、傳真、網址 ﹚
公司簡介:
*
公司名稱
*
E-mail
*
國家
Please Select Your Country
United States
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaidjan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
Former Czechoslovakia
Former USSR
France
France (European Territory)
French Guyana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Great Britain
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion (French)
Romania
Russian Federation
Rwanda
S. Georgia & S. Sandwich Isls.
Saint Helena
Saint Kitts & Nevis Anguilla
Saint Lucia
Saint Pierre and Miquelon
Saint Tome (Sao Tome) and Principe
Saint Vincent & Grenadines
Samoa
San Marino
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Taiwan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City State
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (USA)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe
*
聯絡人
網址
*
電話
-
-
傳真
-
-
*
郵遞區號
*
城市
*
街道地址
*
企業形態
批發商
出口商
進口商
製造商
大盤商
零售商
代理商
Retrofitter
使用者
其他, 請詳細說明:
*
安全密碼
請輸入所顯示的安全密碼
網站導覽 l
隱私權政策 l
服務團隊 l
合作提案 l
聯絡我們 l
幫幫我 l
廣告刊登 l
B2B商業夥伴
.